FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

B Lönnqvist

Research Profile

Procedures

Disorders

Chemicals & Drugs

Living Beings

Infants

Concepts & Ideas

Physiology

Graft Survival

Co-author Network

Publications

TOP 3
Mats Remberger; Johan Aschan; B Lönnqvist; S Carlens; B Gustafsson; Patrik Hentschke; S Klaesson; Jonas Mattsson; Per Ljungman; Olle Ringdén
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
Mats Remberger; Johan Aschan; B Lönnqvist; S Carlens; B Gustafsson; Patrik Hentschke; S Klaesson; Jonas Mattsson; Per Ljungman; Olle Ringdén
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
Patrik Hentschke; Hans Hägglund; Jonas Mattsson; S Carlens; B Lönnqvist; Per Ljungman; Johan Aschan; Sten Fredrikson; Olle Ringdén
Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of B Lönnqvist (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: Mats Remberger; Johan Aschan; B Lönnqvist; S Carlens; B Gustafsson; Patrik Hentschke; S Klaesson; Jonas Mattsson; Per Ljungman; Olle Ringdén
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
Transplantation proceedings 2001;33(1-2):1769-70.
2001: Mats Remberger; Johan Aschan; B Lönnqvist; S Carlens; B Gustafsson; Patrik Hentschke; S Klaesson; Jonas Mattsson; Per Ljungman; Olle Ringdén
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
European journal of haematology 2001;66(1):50-6.
1999: Patrik Hentschke; Hans Hägglund; Jonas Mattsson; S Carlens; B Lönnqvist; Per Ljungman; Johan Aschan; Sten Fredrikson; Olle Ringdén
Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients.
Bone marrow transplantation 1999;24(9):1033-5.
1999: Johan Aschan; Mats Remberger; S Carlens; Jonas Mattsson; M Sirac Dilber; B Lönnqvist; Bo Björkstrand
Unrelated donor stem cell transplantation after autologous transplantation: experience of a single center.
Bone marrow transplantation 1999;24(3):279-82.
1998: Hans Hägglund; Mats Remberger; S Klaesson; B Lönnqvist; Per Ljungman; Olle Ringdén
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.
Blood 1998;92(12):4568-72.
1998: Per Ljungman; Johan Aschan; Ilona Lewensohn-Fuchs; S Carlens; Kajsa Larsson; B Lönnqvist; Jonas Mattsson; Elda Sparrelid; Jacek Winiarski; Olle Ringdén
Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients.
Transplantation 1998;66(10):1330-4.
1998: Elda Sparrelid; Hans Hägglund; Mats Remberger; Olle Ringdén; B Lönnqvist; Per Ljungman; Jan Andersson
Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection.
Bone marrow transplantation 1998;22(8):795-800.
1998: S Carlens; Olle Ringdén; Mats Remberger; B Lönnqvist; Hans Hägglund; S Klaesson; Jonas Mattsson; Britt-Marie Svahn; Jacek Winiarski; Per Ljungman; Johan Aschan
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Bone marrow transplantation 1998;22(8):755-61.
1998: Olle Ringdén; Mats Remberger; S Carlens; H Hagglund; Jonas Mattsson; Johan Aschan; B Lönnqvist; S Klaesson; Jacek Winiarski; Tina Dalianis; Olle Olerup; Elda Sparrelid; A Elmhorn-Rosenborg; Britt-Marie Svahn; Per Ljungman
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
Transplantation 1998;66(5):620-5.
1998: Hans Hägglund; Olle Ringdén; Mats Remberger; B Lönnqvist; Elda Sparrelid; L Tammik; G Kumlien
Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow.
Bone marrow transplantation 1998;22(2):131-6.
1998: Mats Remberger; Olle Ringdén; Per Ljungman; Hans Hägglund; Jacek Winiarski; B Lönnqvist; Johan Aschan
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(1):73-8.
1998: Olle Ringdén; Mats Remberger; Jonas Mattsson; Johan Aschan; S Carlens; Hans Hägglund; B Lönnqvist; Elda Sparrelid; Per Ljungman
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age.
Bone marrow transplantation 1998;21(1):43-9.
1997: Per Ljungman; Hans Hägglund; Bo Björkstrand; B Lönnqvist; Olle Ringdén
Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1997;5(6):485-8.
1997: Olle Ringdén; Mats Remberger; Jonas Mattsson; Johan Aschan; Hans Hägglund; S Carlens; B Lönnqvist; Elda Sparrelid; Per Ljungman
Transplantation with unrelated bone marrow in leukemic patients above 40 years of age.
Transplantation proceedings 1997;29(7):3145-6.
1997: Jonas Mattsson; Olle Ringdén; Johan Aschan; Lisbeth Barkholt; Tina Dalianis; Hans Hägglund; Per Ljungman; B Lönnqvist; J Tollemar; Jacek Winiarski; Mats Remberger
A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate.
Transplantation proceedings 1997;29(1-2):735-6.
1997: B Agren; B Lönnqvist; Bo Björkstrand; U Rudberg; Peter Aspelin
Radiography and bone scintigraphy in bone marrow transplant multiple myeloma patients.
Acta radiologica (Stockholm, Sweden : 1987) 1997;38(1):144-50.
1996: Per Ljungman; M Lawler; B Lönnqvist; Olle Ringdén; A Shanwell
Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions.
Bone marrow transplantation 1996;18(6):1179-81.
1996: H Hágglund; Olle Ringdén; Bo-Göran Ericzon; Frans Duraj; Per Ljungman; B Lönnqvist; Jacek Winiarski; Gunnar Tydén
Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation.
Transplantation 1996;62(8):1076-80.
1996: Per Ljungman; Gunnar Oberg; Johan Aschan; A Ehrnst; B Lönnqvist; Karlis Pauksen; P Sulila
Foscarnet for pre-emptive therapy of CMV infection detected by a leukocyte-based nested PCR in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1996;18(3):565-8.
1996: Per Ljungman; J Andersson; Johan Aschan; Bo Björkstrand; Hans Hägglund; B Lönnqvist; Olle Ringdén; Jacek Winiarski
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(1):167-9.
1996: Per Ljungman; K Loré; Johan Aschan; S Klaesson; Ilona Lewensohn-Fuchs; B Lönnqvist; Olle Ringdén; Jacek Winiarski; A Ehrnst
Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1996;17(4):583-7.
1995: B Lönnqvist; Per Ljungman; M Norrby; O Olerup; O Ringdén; J Winiarski
Less acute GVHD in patients receiving totally matched transplants from unrelated donors.
Transplantation proceedings 1995;27(6):3528-9.
1995: Per Ljungman; N Johansson; Johan Aschan; H Glaumann; B Lönnqvist; Olle Ringdén; Elda Sparrelid; Anders Sönnerborg; Jacek Winiarski; Gösta Gahrton
Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients.
Blood 1995;86(4):1614-8.
1994: Olle Ringdén; Mats Remberger; Johan Aschan; P Lungman; B Lönnqvist; L Markling
Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Transplantation 1994;58(8):887-91.
1994: Per Ljungman; Ilona Lewensohn-Fuchs; V Hammarström; Johan Aschan; L Brandt; P Bolme; B Lönnqvist; N Johansson; Olle Ringdén; Gösta Gahrton
Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation.
Blood 1994;84(2):657-63.
1994: Johan Aschan; Olle Ringdén; E Andström; Per Ljungman; B Lönnqvist; Mats Remberger
Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.
Bone marrow transplantation 1994;14(1):79-87.
1994: Olle Ringdén; Mats Remberger; U Persson; Per Ljungman; Johan Aschan; P Bolme; G Dahllöf; Tina Dalianis; G Gahrton; B Lönnqvist
[New facts about bone marrow transplantation. An unrelated donor is as good as a related one].
Läkartidningen 1994;91(26-27):2577-82.
1994: Gordana Bogdanovic; Maria Brytting; Paola Cinque; M Grandien; E Fridell; P Ljungman; B Lönnqvist; Anna-Lena Hammarin
Nested PCR for detection of BK virus and JC virus DNA.
Clinical and diagnostic virology 1994;2(3):211-20.
1994: Mats Remberger; O Ringden; Johan Aschan; Per Ljungman; B Lönnqvist; L Markling
Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Transplantation proceedings 1994;26(3):1829-30.
1994: S Klaesson; Olle Ringdén; Per Ljungman; B Lönnqvist; Lars Wennberg
Treatment with erythropoietin after allogeneic bone marrow transplantation: a randomized, double-blind study.
Transplantation proceedings 1994;26(3):1827-8.
1994: L Boström; Maria Brytting; Mehrdad Mousavi-Jazi; O Ringden; Per Ljungman; B Lönnqvist; B Wahren; V A Sundqvist
PCR detection of CMV DNA in peripheral blood leucocytes and plasma from BMT recipients.
Transplantation proceedings 1994;26(3):1723-4.
1994: Gordana Bogdanovic; Maria Brytting; Paola Cinque; M Grandien; E Fridell; P Ljungman; B Lönnqvist; Anna-Lena Hammarin
Nested PCR for detection of BK virus and JC virus DNA.
Clinical and diagnostic virology 1994;2(2):127-36.
1994: S Klaesson; Olle Ringdén; Per Ljungman; B Lönnqvist; Lars Wennberg
Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
Bone marrow transplantation 1994;13(4):397-402.
1993: Per Olsson; R Gustafson; V Hammarström; B Lönnqvist; C I Edvard Smith; Lennart Hammarström
Transfer by BMT of IgG2 deficiency involving an immunoglobulin heavy chain constant region deletion and a silent IgG2 gene.
Bone marrow transplantation 1993;11(5):409-14.
1993: Johan Aschan; Olle Ringdén; B Sundberg; S Klaesson; Per Ljungman; B Lönnqvist
Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease.
European journal of haematology 1993;50(5):269-74.
1993: B Lönnqvist; Jan Palmblad; Per Ljungman; Gunnar Grimfors; M Järnmark; R Lerner; C Nyström-Rosander; Gunnar Oberg
Oral acyclovir as prophylaxis for bacterial infections during induction therapy for acute leukaemia in adults. The Leukemia Group of Middle Sweden.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1993;1(3):139-44.
1993: Per Ljungman; Johan Aschan; J N Azinge; L Brandt; A Ehrnst; V Hammarström; S Klaesson; A Linde; B Lönnqvist; Olle Ringdén
Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation.
British journal of haematology 1993;83(1):118-24.
1992: Jan Palmblad; B Lönnqvist; B Carlsson; Gunnar Grimfors; M Järnmark; R Lerner; Per Ljungman; C Nyström-Rosander; B Petrini; Gunnar Oberg
Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias.
Journal of internal medicine 1992;231(4):363-70.
1992: Jan Samuelsson; B Lönnqvist; Jan Palmblad; Gunnar Grimfors; M Järnmark; R Lerner; Per Ljungman; C Nyström-Rosander; Gunnar Oberg
Ceftazidime as initial therapy in febrile patients with acute leukemia during induction chemotherapy. Leukemia Group of Middle Sweden.
Scandinavian journal of infectious diseases 1992;24(1):89-96.
1992: Olle Ringdén; S Klaesson; B Sundberg; Per Ljungman; B Lönnqvist; U Persson
Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.
Bone marrow transplantation 1992;9(1):19-25.
1992: Johan Aschan; Olle Ringdén; Per Ljungman; B Lönnqvist; S Ohlman
Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.
Scandinavian journal of infectious diseases 1992;24(2):143-50.
1991: Per Ljungman; Johan Aschan; P Bolme; R Lindqvist; B Lönnqvist; Olle Ringdén; Jacek Winiarski; G Gahrton
[Bone marrow transplantation or antithymocyte globulin in aplastic anemia? Both therapeutic alternatives result in good quality of life].
Läkartidningen 1991;88(25):2308-11.
1991: Olle Ringdén; P Pihlstedt; L Markling; Johan Aschan; I Båryd; Per Ljungman; B Lönnqvist; J Tollemar; G Janossy; B Sundberg
Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.
Bone marrow transplantation 1991;7(3):221-6.
1990: Per Ljungman; M Wiklund-Hammarsten; V Duraj; Lennart Hammarström; B Lönnqvist; T Paulin; Olle Ringdén; M S Pepe; Gösta Gahrton
Response to tetanus toxoid immunization after allogeneic bone marrow transplantation.
The Journal of infectious diseases 1990;162(2):496-500.
1990: Johan Aschan; O Ringdén; B Sundberg; L Markling; B Lönnqvist; P Ljungman; J Tollemar; Agneta Shanwell; A Heimdahl; E Möller
[Prolonged survival after bone marrow transplantation in patients older than 30 years of age].
Läkartidningen 1990;87(10):752-4, 756.
1990: Olle Ringdén; Carl G Groth; Johan Aschan; P Bolme; Per Ljungman; B Lönnqvist; Gunilla Malm; J E Månsson; Agneta Shanwell; L Svennerholm
Bone marrow transplantation for metabolic disorders at Huddinge Hospital.
Transplantation proceedings 1990;22(1):198-202.
1990: Johan Aschan; Olle Ringdén; J Tollemar; Per Ljungman; B Lönnqvist; P Pihlstedt; L Markling; B Sundberg
Improved survival in marrow recipients above 30 years of age with better prevention of graft-versus-host disease.
Transplantation proceedings 1990;22(1):195-7.
1990: Per Ljungman; A Ehrnst; Bo Björkstrand; E Hellström; H Ingelman-Sundberg; Gunnar Juliusson; B Lönnqvist
Lethal disseminated adenovirus type 1 infection in a patient with chronic lymphocytic leukemia.
Scandinavian journal of infectious diseases 1990;22(5):601-5.
1989: Per Ljungman; B Lönnqvist; O Ringdén; P Skinhöj; Gösta Gahrton
A randomized trial of oral versus intravenous acyclovir for treatment of herpes zoster in bone marrow transplant recipients. Nordic Bone Marrow Transplant Group.
Bone marrow transplantation 1989;4(6):613-5.
1989: Per Ljungman; E Fridell; B Lönnqvist; P Bolme; M Böttiger; Gösta Gahrton; A Linde; Olle Ringdén; B Wahren
Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
The Journal of infectious diseases 1989;159(4):610-5.
1989: J Tollemar; Olle Ringdén; L Bäckman; G Janossy; B Lönnqvist; L Markling; P Philstedt; B Sundberg
Results of four different protocols for prophylaxis against graft-versus-host disease.
Transplantation proceedings 1989;21(1 Pt 3):3008-10.
1989: Olle Ringdén; P Bolme; B Lönnqvist; Göran Gustafsson; A Kreuger
Allogeneic bone marrow transplantation versus chemotherapy in children with acute leukemia in Sweden.
Pediatric hematology and oncology 1989;6(2):137-44.
1989: J Tollemar; K Holmberg; Olle Ringdén; B Lönnqvist
Surveillance tests for the diagnosis of invasive fungal infections in bone marrow transplant recipients.
Scandinavian journal of infectious diseases 1989;21(2):205-12.
1988: G Norhagen-Engström; Lennart Hammarström; B Lönnqvist; P O Söder; C I Edvard Smith
Ontogeny of immunoglobulins in bone marrow-transplanted individuals. An analysis of serum and salivary levels.
Transplantation 1988;46(5):710-5.
1988: L Bäckman; Olle Ringdén; J Tollemar; B Lönnqvist
An increased risk of relapse in cyclosporin-treated compared with methotrexate-treated patients: long-term follow-up of a randomized trial.
Bone marrow transplantation 1988;3(5):463-71.
1988: Olle Ringdén; B Sundberg; B Lönnqvist; J Tollemar; Gösta Gahrton; B Nilsson
Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse.
Bone marrow transplantation 1988;3(4):281-90.
1988: J Tollemar; Olle Ringdén; B Sundberg; P Bolme; Christina Brattström; G Gahrton; L Johansen; B Lönnqvist
Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate.
Transplantation proceedings 1988;20(3):494-8.
1988: J Tollemar; Olle Ringdén; A Heimdahl; B Lönnqvist; B Sundberg
Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate.
Transplantation proceedings 1988;20(3 Suppl 3):470-9.
1988: J Tollemar; Olle Ringdén; K Holmberg; B Lönnqvist
Serologic surveillance for evidence of deep disseminating fungal infections in bone marrow transplantation recipients.
Transplantation proceedings 1988;20(3):501-2.
1988: Olle Ringdén; P Bolme; B Lönnqvist; J Tollemar; B Borgström; G Dohlhöf; G Lundgren; Jacek Winiarski; G Gahrton; Carl G Groth
Allogeneic bone marrow transplantation in children at Huddinge Hospital.
Transplantation proceedings 1988;20(3):487-90.
1987: Olle Ringdén; P Pihlstedt; L Volin; J Nikoskelainen; B Lönnqvist; P Ruutu; T Ruutu; A Toivanen; B Wahren
Failure to prevent cytomegalovirus infection by cytomegalovirus hyperimmune plasma: a randomized trial by the Nordic Bone Marrow Transplantation Group.
Bone marrow transplantation 1987;2(3):299-305.
1987: L Ost; B Lönnqvist; L Eriksson; Per Ljungman; Olle Ringdén
Hemorrhagic cystitis--a manifestation of graft versus host disease?
Bone marrow transplantation 1987;2(1):19-25.
1986: Per Ljungman; H Wilczek; Gösta Gahrton; A Gustavsson; G Lundgren; B Lönnqvist; Olle Ringdén; B Wahren
Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
Bone marrow transplantation 1986;1(2):185-92.
1986: Olle Ringdén; L Bäckman; B Lönnqvist; A Heimdahl; A Lindholm; P Bolme; G Gahrton
A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies.
Bone marrow transplantation 1986;1(1):41-51.
1982: Olle Ringdén; B Lönnqvist; G Lundgren; G Gahrton; C G Groth; E Möller; I Båryd; B Johansson; P Pihlstedt; B Gullbring
Experience with a cooperative bone marrow transplantation program in Stockholm.
Transplantation 1982;33(5):500-4.